ROBERT HERSHBERG, a director at $ATAI, sold 100,000 shares of the company on 07-07-2026 for an estimated $496,000. We received data on the trade from a recent SEC filing. This was a sale of approximately 50.0% of their shares of this class of stock. Following this trade, they now own 100,000 shares of this class of $ATAI stock.
$ATAI Insider Trading Activity
$ATAI insiders have traded $ATAI stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $ATAI stock by insiders over the last 6 months:
- KEVIN JAMES CRAIG (Chief Medical Officer) has made 0 purchases and 3 sales selling 185,158 shares for an estimated $759,926.
- ROBERT HERSHBERG sold 100,000 shares for an estimated $496,000
- GERD KOCHENDOERFER (Chief Operating Officer) sold 50,000 shares for an estimated $250,000
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$ATAI Hedge Fund Activity
We have seen 94 institutional investors add shares of $ATAI stock to their portfolio, and 49 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS GROUP AG added 7,426,867 shares (+inf%) to their portfolio in Q1 2026, for an estimated $26,253,974
- DEEP TRACK CAPITAL, LP added 7,322,711 shares (+156.6%) to their portfolio in Q1 2026, for an estimated $25,885,783
- SUSQUEHANNA INTERNATIONAL GROUP, LLP added 4,678,798 shares (+770.1%) to their portfolio in Q1 2026, for an estimated $16,539,550
- MILLENNIUM MANAGEMENT LLC added 4,364,096 shares (+inf%) to their portfolio in Q1 2026, for an estimated $15,427,079
- BLACKROCK, INC. added 4,022,092 shares (+143.0%) to their portfolio in Q1 2026, for an estimated $14,218,095
- CANDRIAM S.C.A. added 3,086,379 shares (+inf%) to their portfolio in Q1 2026, for an estimated $10,910,349
- GEODE CAPITAL MANAGEMENT, LLC added 2,509,974 shares (+inf%) to their portfolio in Q1 2026, for an estimated $8,872,758
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$ATAI Analyst Ratings
Wall Street analysts have issued reports on $ATAI in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 06/08/2026
- Guggenheim issued a "Buy" rating on 01/20/2026
To track analyst ratings and price targets for $ATAI, check out Quiver Quantitative's $ATAI forecast page.
$ATAI Price Targets
Multiple analysts have issued price targets for $ATAI recently. We have seen 6 analysts offer price targets for $ATAI in the last 6 months, with a median target of $15.0.
Here are some recent targets:
- Sumant Kulkarni from Canaccord Genuity set a target price of $17.0 on 07/07/2026
- Andrew Tsai from Jefferies set a target price of $10.0 on 07/06/2026
- Patrick R. Trucchio from HC Wainwright & Co. set a target price of $25.0 on 06/08/2026
- Eddie Hickman from Guggenheim set a target price of $16.0 on 04/17/2026
- David Hoang from Deutsche Bank set a target price of $12.0 on 03/27/2026
- Ami Fadia from Needham set a target price of $14.0 on 03/09/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
